Longitudinal analysis showed that the expression of IGHV4-39 possessed a similar trend, while MBL2 and LTA showed an opposite trend to tumor size, which may have the potential to predict cancer recurrence after therapy (Fig. 3H, I). This evidence concerns the gene MBL2 and neoplasm.